Opioids in Remote Ischemic Preconditioning-Induced Cardioprotection

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 22, Issue 2, 2017, Pages 112-121

  Randhawa, Puneet Kaur ^a   Jaggi, Amteshwar Singh ^a  

^a PUNJABI UNIVERSITY   (India)

Author keywords

cardioprotection; humoral; opioids; remote ischemic preconditioning

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; DELTA OPIATE RECEPTOR; DYNORPHIN; ENDORPHIN; ENKEPHALIN; KAPPA OPIATE RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; TRAMADOL;

CORONARY ARTERY BYPASS GRAFT; DRUG EFFECT; HEART INFARCTION; HEART MUSCLE INJURY; HEART PROTECTION; HUMAN; ISCHEMIC PRECONDITIONING; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; NONHUMAN; PROTEIN FUNCTION; REMOTE ISCHEMIC PRECONDITIONING; REVIEW; SEROTONIN SYNDROME; SIGNAL TRANSDUCTION;

EID: 85011333346     PISSN: 10742484     EISSN: 19404034     Source Type: Journal    
DOI: 10.1177/1074248416660621     Document Type: Review

References (85)

1. Randhawa PK, Bali A, Jaggi AS,. RIPC for multiorgan salvage in clinical settings: evolution of concept, evidences and mechanisms. Eur J Pharmacol. 2015; 746: 317-332.
2. Sharma R, Randhawa PK, Singh N, Jaggi AS,. Possible role of thromboxane A2 in remote hind limb preconditioning-induced cardioprotection. Naunyn Schmiedebergs Arch Pharmacol. 2016; 389 (1): 1-9.
3. Randhawa PK, Jaggi AS,. TRPV1 and TRPV4 channels: potential therapeutic targets for ischemic conditioning-induced cardioprotection. Eur J Pharmacol. 2015; 746: 180-185.
4. Lim SY, Yellon DM, Hausenloy DJ,. The neural and humoral pathways in remote limb ischemic preconditioning. Basic Res Cardiol. 2010; 105 (5): 651-655.
5. Hausenloy DJ, Yellon DM,. Remote ischaemic preconditioning: underlying mechanisms and clinical application. Cardiovasc Res. 2008; 79 (3): 377-386.
6. Mayfield KP, D'Alecy LG,. Role of endogenous opioid peptides in the acute adaptation to hypoxia. Brain Res. 1992; 582 (2): 226-231.
7. Takasaki Y, Wolff RA, Chien GL, van Winkle DM,. Met5-enkephalin protects isolated adult rabbit cardiomyocytes via delta-opioid receptors. Am J Physiol. 1999; 277 (6 pt 2): H2442-H2450.
8. Bolling SF, Badhwar V, Schwartz CF, et al. Opioids confer myocardial tolerance to ischemia: interaction of delta opioid agonists and antagonists. J Thorac Cardiovasc Surg. 2001; 122 (3): 476-481.
9. St Marie B., Primary care experiences of people who live with chronic pain and receive opioids to manage pain: a qualitative methodology. J Am Assoc Nurse Pract. 2016; 28 (8): 429-435.
10. Zeng X, Zhao X, Yang Y, et al. Opioid (1) and (2) receptor agonist attenuate myocardial injury via mPTP in rats with acute hemorrhagic shock. J Surg Res. 2011; 169 (2): 267-276.
11. Barron BA,. Opioid peptides and the heart. Cardiovasc Res. 1999; 43 (1): 13-16.
12. Valtchanova-Matchouganska A, Ojewole JA,. Mechanisms of opioid delta (delta) and kappa (kappa) receptors' cardioprotection in ischaemic preconditioning in a rat model of myocardial infarction. Cardiovasc J S Afr. 2003; 14 (2): 73-80.
13. Patel HH, Moore J, Hsu AK, Gross GJ,. Cardioprotection at a distance: mesenteric artery occlusion protects the myocardium via an opioid sensitive mechanism. J Mol Cell Cardiol. 2002; 34 (10): 1317-1323.
14. Weinbrenner C, Schulze F, Sárváry L, Strasser RH,. Remote preconditioning by infrarenal aortic occlusion is operative via delta1-opioid receptors and free radicals in vivo in the rat heart. Cardiovasc Res. 2004; 61 (3): 591-599.
15. Zhang SZ, Wang NF, Xu J, et al. Kappa-opioid receptors mediate cardioprotection by remote preconditioning. Anesthesiology. 2006; 105 (3): 550-556.
16. Shimizu M, Tropak M, Diaz RJ, et al. Transient limb ischaemia remotely preconditions through a humoral mechanism acting directly on the myocardium: evidence suggesting cross-species protection. ClinSci (Lond). 2009; 117 (5): 191-200.
17. Wong GT, Lu Y, Mei B, et al. Cardioprotection from remote preconditioning involves spinal opioid receptor activation. Life Sci. 2012; 91 (17-18): 860-865.
18. D'Ascenzo F, Moretti C, Omedè P, et al. Cardiac remote ischaemic preconditioning reduces periprocedural myocardial infarction for patients undergoing percutaneous coronary interventions: a meta-analysis of randomised clinical trials. Eurointervention. 2014; 9 (12): 1463-1471.
19. Vignaud A, Hourde C, Medja F, et al. Impaired skeletal muscle repair after ischemia-reperfusion injury in mice. J Biomed Biotechnol. 2010; 2010: 724914.
20. Deng QW, Xia ZQ, Qiu YX, et al. Clinical benefits of aortic cross-clamping versus limb remote ischemic preconditioning in coronary artery bypass grafting with cardiopulmonary bypass: a meta-analysis of randomized controlled trials. J Surg Res. 2015; 193 (1): 52-68.
21. Davies WR, Brown AJ, Watson W, et al. Remote ischemic preconditioning improves outcome at 6 years after elective percutaneous coronary intervention: the CRISP stent trial long-term follow-up. Circ Cardiovasc Interv. 2013; 6 (3): 246-251.
22. Liu Z, Gong R,. Remote ischemic preconditioning for kidney protection: GSK3β-centric insights into the mechanism of action. Am J Kidney Dis. 2015; 66 (5): 846-856.
23. Wu J, Feng X, Huang H, et al. Remote ischemic conditioning enhanced the early recovery of renal function in recipients after kidney transplantation: a randomized controlled trial. J Surg Res. 2014; 188 (1): 303-308.
24. Hudetz JA, Patterson KM, Iqbal Z, Gandhi SD, Pagel PS,. Remote ischemic preconditioning prevents deterioration of short-term postoperative cognitive function after cardiac surgery using cardiopulmonary bypass: results of a pilot investigation. J Cardiothorac Vasc Anesth. 2015; 29 (2): 382-388.
25. Min JJ, Bae JY, Kim TK, et al. Pulmonary protective effects of remote ischaemic preconditioning with postconditioning in patients undergoing cardiac surgery involving cardiopulmonary bypass: a substudy of the remote ischaemic preconditioning with postconditioning outcome trial. Heart Lung Circ. 2016; 25 (5): 484-492.
26. Jones H, Hopkins N, Bailey TG, et al. Seven-day remote ischemic preconditioning improves local and systemic endothelial function and microcirculation in healthy humans. Am J Hypertens. 2014; 27 (7): 918-925.
27. Schulman D, Latchman DS, Yellon DM,. Effect of aging on the ability of preconditioning to protect rat hearts from ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 2001; 281 (4): H1630-H1636.
28. Boengler K, Konietzka I, Buechert A, et al. Loss of ischemic preconditioning's cardioprotection in aged mouse hearts is associated with reduced gap junctional and mitochondrial levels of connexin 43. Am J Physiol Heart Circ Physiol. 2007; 292 (4): H1764-H1769.
29. Abete P, Ferrara N, Cioppa A, et al. Preconditioning does not prevent postischemic dysfunction in aging heart. J Am Coll Cardiol. 1996; 27 (7): 1777-1786.
30. Vasile VC, Babuin L, Giannitsis E, Katus HA, Jaffe AS,. Relationship of MRI-determined infarct size and cTnI measurements in patients with ST-elevation myocardial infarction. Clin Chem. 2008; 54 (3): 617-619.
31. Abete P, Ferrara N, Cacciatore F, et al. Angina-induced protection against myocardial infarction in adult and elderly patients: a loss of preconditioning mechanism in the aging heart? J Am Coll Cardiol. 1997; 30 (4): 947-954.
32. Ishihara M, Sato H, Tateishi H, et al. Beneficial effect of prodromal angina pectoris is lost in elderly patients with acute myocardial infarction. Am Heart J. 2000; 139 (5): 881-888.
33. Longobardi G, Abete P, Ferrara N, et al. "Warm-up" phenomenon in adult and elderly patients with coronary artery disease: further evidence of the loss of "ischemic preconditioning" in the aging heart. J Gerontol A Biol Sci Med Sci. 2000; 55 (3): M124-M129.
34. Moro L, Pedone C, Mondì A, Nunziata E, Antonelli Incalzi R,. Effect of local and remote ischemic preconditioning on endothelial function in young people and healthy or hypertensive elderly people. Atherosclerosis. 2011; 219 (2): 750-752.
35. Jensen RV, Zachara NE, Nielsen PH, et al. Impact of O-GlcNAc on cardioprotection by remote ischaemic preconditioning in non-diabetic and diabetic patients. Cardiovasc Res. 2013; 97 (2): 369-378.
36. Cleveland JC Jr, Meldrum DR, Cain BS,. Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium. Two paradoxes revisited. Circulation. 1997; 96 (1): 29-32.
37. Loubani M, Fowler A, Standen NB, Galiñanes M,. The effect of gliclazide and glibenclamide on preconditioning of the human myocardium. Eur J Pharmacol. 2005; 515 (1-3): 142-149.
38. Lucchinetti E, Bestmann L, Feng J, et al. Remote ischemic preconditioning applied during isoflurane inhalation provides no benefit to the myocardium of patients undergoing on-pump coronary artery bypass graft surgery: lack of synergy or evidence of antagonism in cardioprotection? Anesthesiology. 2012; 116 (2): 296-310.
39. Kottenberg E, Musiolik J, Thielmann, et al. Interference of propofol with signal transducer and activator of transcription 5 activation and cardioprotection by RIPC during coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2014; 147 (1): 376-382.
40. Howlett TA, Tomlin S, Ngahfoong L, et al. Release of beta endorphin and met-enkephalin during exercise in normal women: response to training. Br Med J (Clin Res Ed). 1984; 288 (6435): 1950-1952.
41. Matejec R, Schulz A, Harbach HW, et al. Effects of tourniquet-induced ischemia on the release of proopiomelanocortin derivatives determined in peripheral blood plasma. J Appl Physiol (1985). 2004; 97 (3): 1040-1045.
42. Jackson KE, Farias M, Stanfill AS, Caffrey JL,. Transient arterial occlusion raises enkephalin in the canine sinoatrial node and improves vagal bradycardia. Auton Neurosci. 2001; 94 (1-2): 84-92.
43. Maslov LN, Naryzhnaia NV, Tsibulnikov SY, et al. Role of endogenous opioid peptides in the infarct size-limiting effect of adaptation to chronic continuous hypoxia. Life Sci. 2013; 93 (9-11): 373-379.
44. Michelsen MM, Støttrup NB, Schmidt MR, et al. Exercise-induced cardioprotection is mediated by a bloodborne, transferable factor. Basic Res Cardiol. 2012; 107 (3): 260.
45. Surendra H, Diaz RJ, Harvey K, et al. Interaction of and opioid receptors with adenosine A1 receptors mediates cardioprotection by remote ischemic preconditioning. J Mol Cell Cardiol. 2013; 60: 142-150.
46. Lu Y, Dong CS, Yu JM, Li H,. Morphine reduces the threshold of remote ischemic preconditioning against myocardial ischemia and reperfusion injury in rats: the role of opioid receptors. J Cardiothorac Vasc Anesth. 2012; 26 (3): 403-406.
47. Andreadou I, Bibli SI, Mastromanolis E, et al. Transient carotid ischemia as a remote conditioning stimulus for myocardial protection in anesthetized rabbits: insights into intracellular signaling. Int J Cardiol. 2015; 184: 140-151.
48. Lu Y, Hu J, Dong C,. Morphine may enhance the cardioprotection induced by remote ischemic preconditioning. Int J Cardiol. 2015; 187: 443-444.
49. Lu Y, Hu J, Zhang Y, Dong CS, Wong GT,. Remote intrathecal morphine preconditioning confers cardioprotection via spinal cord nitric oxide/cyclic guanosine monophosphate/protein kinase G pathway. J Surg Res. 2015; 193 (1): 43-51.
50. Andreadou I, Farmakis D, Iliodromitis EK,. Ligands involved in conditioning may enhance the protection afforded by remote ischemia and reperfusion. Int J Cardiol. 2015; 190: 273-274.
51. Wagner R, Piler P, Bedanova H, et al. Myocardial injury is decreased by late remote ischaemic preconditioning and aggravated by tramadol in patients undergoing cardiac surgery: a randomised controlled trial. Interact Cardiovasc Thorac Surg. 2010; 11 (6): 758-762.
52. Bilir A, Erkasap N, Koken T, et al. Effects of tramadol on myocardial ischemia-reperfusion injury. Scand Cardiovasc J. 2007; 41 (4): 242-247.
53. Takhtfooladi HA, Asl AH, Shahzamani M, et al. Tramadol alleviates myocardial injury induced by acute hind limb ischemia reperfusion in rats. Arq Bras Cardiol. 2015; 105 (2): 151-159.
54. Golino P, Piscione F, Willerson JT, et al. Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients. N Engl J Med. 1991; 324 (10): 641-648.
55. Addison PD, Neligan PC, Ashrafpour H, et al. Noninvasive remote ischemic preconditioning for global protection of skeletal muscle against infarction. Am J Physiol Heart Circ Physiol. 2003; 285 (4): H1435-H1443.
56. Perrelli MG, Pagliaro P, Penna C,. Ischemia/reperfusion injury and cardioprotective mechanisms: role of mitochondria and reactive oxygen species. World J Cardiol. 2011; 3 (6): 186-200.
57. Sobanski P, Krajnik M, Shaqura M, et al. The presence of mu-, delta-, and kappa-opioid receptors in human heart tissue. Heart Vessels. 2014; 29 (6): 855-863.
58. Hung CF, Li HJ, Chang HH, Lee GA, Su MJ,. The differential effects of a selective kappa-opioid receptor agonist, U50488, in guinea pig heart tissues. Biomed Res Int. 2015; 2015: 906039.
59. Tsai HJ, Huang SS, Tsou MT, Wang HT, Chiu JH,. Role of opioid receptors signaling in remote electrostimulation-induced protection against ischemia/reperfusion injury in rat hearts. PLoS One. 2015; 10 (10): e0138108.
60. Fraessdorf J, Hollmann MW, Hanschmann I, et al. Role of endogenous opioid system in ischemic-induced late preconditioning. PLoS One. 2015; 10 (7): e0134283.
61. Wever KE, Masereeuw R, Wagener FA, et al. Humoral signalling compounds in remote ischaemic preconditioning of the kidney, a role for the opioid receptor. Nephrol Dial Transplant. 2013; 28 (7): 1721-1732.
62. Barna TJ, Denning GM, Ackermann LW, et al. Skeletal muscle, heart, and intestine are sources, as well as targets of opioid peptides. The Faseb J. 2007; 21 (6): A866.
63. Fryer RM, Hsu AK, Gross GJ,. ERK and p38 MAP kinase activation are components of opioid-induced delayed cardioprotection. Basic Res Cardiol. 2001; 96 (2): 136-142.
64. He SF, Jin SY, Wu H, et al. Morphine preconditioning confers cardioprotection in doxorubicin-induced failing rat hearts via ERK/GSK-3β pathway independent of PI3K/Akt. Toxicol Appl Pharmacol. 2015; 288 (3): 349-358.
65. Philipp S, Critz SD, Cui L, et al. Localizing extracellular signal-regulated kinase (ERK) in pharmacological preconditioning's trigger pathway. Basic Res Cardiol. 2006; 101 (2): 159-167.
66. Li J, Xuan W, Yan R, et al. Remote preconditioning provides potent cardioprotection via PI3K/Akt activation and is associated with nuclear accumulation of β-catenin. Clin Sci (Lond). 2011; 120 (10): 451-462.
67. Rassaf T, Totzeck M, Hendgen-Cotta UB, et al. Circulating nitrite contributes to cardioprotection by remote ischemic preconditioning. Circ Res. 2014; 114 (10): 1601-1610.
68. Heidbreder M, Naumann A, Tempel K, Dominiak P, Dendorfer A,. Remote vs. ischaemic preconditioning: the differential role of mitogen-activated protein kinase pathways. Cardiovasc Res. 2008; 78 (1): 108-115.
69. Konstantinov IE, Li J, Cheung MM, et al. Remote ischemic preconditioning of the recipient reduces myocardial ischemia-reperfusion injury of the denervated donor heart via a Katp channel-dependent mechanism. Transplantation. 2005; 79 (12): 1691-1695.
70. Gross ER, Hsu AK, Gross GJ,. Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts. Circ Res. 2004; 94 (7): 960-966.
71. Small BA, Lu Y, Hsu AK, Gross GJ, Gross ER,. Morphine reduces myocardial infarct size via heat shock protein 90 in rodents. Biomed Res Int. 2015; 2015: 129612.
72. Dorsch M, Behmenburg F, Raible M, et al. Morphine-induced preconditioning: involvement of protein kinase A and mitochondrial permeability transition pore. PLoS One. 2016; 11 (3): e0151025.
73. Pepe S, Liaw NY, Hepponstall M, et al. Effect of remote ischemic preconditioning on phosphorylated protein signaling in children undergoing tetralogy of Fallot repair: a randomized controlled trial. J Am Heart Assoc. 2013; 2 (3): e000095.
74. Liang Y, Li YP, He F, Liu XQ, Zhang JY,. Long-term, regular remote ischemic preconditioning improves endothelial function in patients with coronary heart disease. Braz J Med Biol Res. 2015; 48 (6): 568-576.
75. Zhang WM, Wong TM,. Suppression of cAMP by phosphoinositol/Ca2+ pathway in the cardiac kappa-opioid receptor. Am J Physiol. 1998; 274 (1 pt 1): C82-C87.
76. Frame MD, Mabanta L,. Remote microvascular preconditioning alters specific vasoactive responses. Microcirculation. 2007; 14 (7): 739-751.
77. Wong TM, Wu S,. Roles of kappa opioid receptors in cardioprotection against ischemia: the signaling mechanisms. Sheng Li Xue Bao. 2003; 55 (2): 115-120.
78. Peart JN, Gross ER, Reichelt ME, et al. Activation of kappa-opioid receptors at reperfusion affords cardioprotection in both rat and mouse hearts. Basic Res Cardiol. 2008; 103 (5): 454-463.
79. Weinbrenner C, Nelles M, Herzog N, Sárváry L, Strasser RH,. Remote preconditioning by infrarenal occlusion of the aorta protects the heart from infarction: a newly identified non-neuronal but PKC-dependent pathway. Cardiovasc Res. 2002; 55 (3): 590-601.
80. Randhawa PK, Jaggi AS,. Unraveling the role of adenosine in remote ischemic preconditioning-induced cardioprotection. Life Sci. 2016; 155: 140-146.
81. Loukogeorgakis SP, Williams R, Panagiotidou AT, et al. Transient limb ischemia induces remote preconditioning and remote postconditioning in humans by a K(ATP)-channel dependent mechanism. Circulation. 2007; 116 (12): 1386-1395.
82. Yao L, Wong GT, Xia Z, Irwin MG,. Interaction between spinal opioid and adenosine receptors in remote cardiac preconditioning: effect of intrathecal morphine. J Cardiothorac Vasc Anesth. 2011; 25 (3): 444-448.
83. Peart JN, Gross GJ,. Adenosine and opioid receptor-mediated cardioprotection in the rat: evidence for cross-talk between receptors. Am J Physiol Heart Circ Physiol. 2003; 285 (1): H81-H89.
84. Sharma NK, Mahadevan N, Balakumar P,. Adenosine transport blockade restores attenuated cardioprotective effects of adenosine preconditioning in the isolated diabetic rat heart: potential crosstalk with opioid receptors. Cardiovasc Toxicol. 2013; 13 (1): 22-32.
85. Lee YC, Jung J, Park SJ,. Remifentanil-induced preconditioning has cross-talk with A1 and A2B adenosine receptors in ischemic-reperfused rat heart. Bosn J Basic Med Sci. 2016; 16 (1): 64-70.